Your browser doesn't support javascript.
loading
A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins.
Casalino, Evan; Stine, Laurel B; Corin, Aaron J; Thai, Chuong-Thu; Quiroz, Jose; Wilson, Stephen C; Labow, Mark; Mittal, Shuchi.
Afiliação
  • Casalino E; Neuroscience Thematic Research Center, Bristol Myers Squibb, Cambridge, MA, United States.
  • Stine LB; Inflammation, Cardiovascular and Fibrosis Thematic Research Center, Bristol Myers Squibb, Cambridge, MA, United States.
  • Corin AJ; Inflammation, Cardiovascular and Fibrosis Thematic Research Center, Bristol Myers Squibb, Cambridge, MA, United States.
  • Thai CT; Compound Management, Automation and Assay Technology, Bristol Myers Squibb, San Diego, CA, United States.
  • Quiroz J; Compound Management, Automation and Assay Technology, Bristol Myers Squibb, San Diego, CA, United States.
  • Wilson SC; Inflammation, Cardiovascular and Fibrosis Thematic Research Center, Bristol Myers Squibb, Cambridge, MA, United States.
  • Labow M; Neuroscience Thematic Research Center, Bristol Myers Squibb, Cambridge, MA, United States. Electronic address: mark.labow@bms.com.
  • Mittal S; Neuroscience Thematic Research Center, Bristol Myers Squibb, Cambridge, MA, United States. Electronic address: shuchi.mittal@bms.com.
SLAS Discov ; 27(6): 349-357, 2022 09.
Article em En | MEDLINE | ID: mdl-35580766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article